Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has updated the intervention type to 'Verified 2019-11 by Tianjin Medical University Second Hospital' and noted a revision to version 2.14.0, while removing the previous intervention type and revision 2.13.3.
    Difference
    3%
    Check dated 2025-01-12T18:15:04.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:48:10.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T16:18:52.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has added new features for data download options, including formats like CSV, JSON, and FHIR, while removing several key government health-related links.
    Difference
    14%
    Check dated 2024-11-23T04:40:39.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    New additions include several important health and government websites, such as HHS, NIH, NLM, NCBI, and USA.gov.
    Difference
    0.7%
    Check dated 2024-11-15T23:46:50.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options in various file formats and a comprehensive selection of data fields for studies.
    Difference
    16%
    Check dated 2024-11-08T18:23:02.000Z thumbnail image

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.